When was Sunhawk Vision Biotech founded?

Sunhawk Vision Biotech was founded in 2019.

Where is Sunhawk Vision Biotech located?

Sunhawk Vision Biotech is headquartered in Kaohsiung City, Taiwan.

Is Sunhawk Vision Biotech a funded company?

Sunhawk Vision Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Sunhawk Vision Biotech rank among its competitors?

Sunhawk Vision Biotech ranks 2575th amongst 2665 active competitors, of which 919 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of Sunhawk Vision Biotech?

Sunhawk Vision Biotech's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Karyopharm secured the most recent funding round in March, 2026.

Sunhawk Vision Biotech - 2026 Company Profile & Competitors

Company Details

Developer of RNA-based ophthalmic solutions for treating eye diseases. The company focuses on the research, development, and clinical trials of therapeutics targeting conditions such as myopia, dry eye disease, and corneal erosion. Its core product is an anti-microRNA-328 ophthalmic solution currently undergoing Phase II clinical trials for multiple indications. The company has received regulatory approvals for clinical trials and has secured strategic investment.

Website: sunhawkvision.com
Email ID: *****@shvbiotech.com
Phone Number: +886 **********, +886 **********

Key Metrics

Founded Year

2019

Location

Kaohsiung City, Taiwan

Stage

Public

Ranked

2575^th among 2665 active competitors

Similar Companies

Moderna & 322 more

Exit Details

Public

View Sunhawk Vision Biotech's full profile

Sunhawk Vision Biotech got listed on Mar 10, 2025.

Click here to take a look at Sunhawk Vision Biotech's IPO in detail

Sunhawk Vision Biotech has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sunhawk Vision Biotech include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Sunhawk Vision Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	Boxer Capital, BVF Partners & 15 others	72/100
4th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Nextech Invest, Third Rock Ventures & 20 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
8th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Zymeworks 2003, Vancouver (Canada), Public	Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer	$146M	CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund ... & 17 others	71/100
2575th	Sunhawk Vision Biotech 2019, Kaohsiung City (Taiwan), Public	Developer of RNA-based ophthalmic solutions for treating eye diseases	-	-	20/100